(Q37337557)

English

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

scientific article published on 06 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

0 references

glucocorticoid-induced osteoporosis

1 reference

based on heuristic

inferred from title

author name string

P Farahmand

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

F Marin

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

F Hawkins

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

R Möricke

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

J D Ringe

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

C-C Glüer

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

N Papaioannou

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

S Minisola

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

G Martínez

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

J M Nolla

10

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

C Niedhart

11

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

N Guañabens

12

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

R Nuti

13

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

E Martín-Mola

14

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

F Thomasius

15

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

J Peña

16

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

C Graeff

17

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

G Kapetanos

18

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

H Petto

19

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

A Gentzel

20

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

A Reisinger

21

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

P K Zysset

22

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

6 June 2013

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Osteoporosis International

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

24

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

2971-2981

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

copyright license

Creative Commons Attribution-NonCommercial 2.0 Generic

6 June 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1007/s00198-013-2379-5

0 references

Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Male-female differences in the association between incident hip fracture and proximal femoral strength: a finite element analysis study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

New imaging modalities in bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Association of hip strength estimates by finite-element analysis with fractures in women and men

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Bone strength measured by peripheral quantitative computed tomography and the risk of nonvertebral fractures: the osteoporotic fractures in men (MrOS) study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Biomechanical computed tomography-noninvasive bone strength analysis using clinical computed tomography scans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Minireview: live and let die: molecular effects of glucocorticoids on bone cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Glucocorticoid-induced osteoporosis: pathophysiology and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

6 September 2017

Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

14 September 2017

Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

14 September 2017

Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

26 June 2018

Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

26 June 2018

Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

26 June 2018

Effect of bone distribution on vertebral strength: assessment with patient-specific nonlinear finite element analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

26 June 2018

Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

High resolution quantitative computed tomography-based assessment of trabecular microstructure and strength estimates by finite-element analysis of the spine, but not DXA, reflects vertebral fracture status in men with glucocorticoid-induced osteopo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Femoral strength in osteoporotic women treated with teriparatide or alendronate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

PINP as an aid for monitoring patients treated with teriparatide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

The utility of changes in serum levels of C-terminal telopeptide of type I collagen in predicting patient response to oral monthly ibandronate therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

A patient-specific finite element methodology to predict damage accumulation in vertebral bodies under axial compression, sagittal flexion and combined loads.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Effect of prior and ongoing raloxifene therapy on response to PTH and maintenance of BMD after PTH therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Monitoring teriparatide-associated changes in vertebral microstructure by high-resolution CT in vivo: results from the EUROFORS study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Development of an algorithm for using PINP to monitor treatment of patients with teriparatide.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Effects of low-dose prednisone on bone metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled,

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3838582

2 September 2018

QCT-based finite element models predict human vertebral strength in vitro significantly better than simulated DEXA

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2379-5

21 January 2018

Improvements in Vertebral Body Strength Under Teriparatide Treatment Assessed In Vivo by Finite Element Analysis: Results From the EUROFORS Study

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2379-5

21 January 2018

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2379-5

21 January 2018

Finite element analysis performed on radius and tibia HR-pQCT images and fragility fractures at all sites in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structural determinants of vertebral fracture risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical markers in glucocorticoid-induced osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid and robust response of biochemical markers of bone formation to teriparatide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00198-013-2379-5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37337557&oldid=2135295145"